Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M--Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M--EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M--ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PID

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

PID is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


PID: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Vanzeyst, Albert Wilhelmus10% Security Holder 2016-02-04Sell135,000$0.861356.98view
Anwyll, Edward William DrewSenior Officer 2016-02-04Sell4,000$18.75-33.17view
Galloway, JulieSenior Officer 2016-02-04Sell16,600$18.5-32.27view
Higgs, Darcy Alan10% Security Holder 2016-02-04Sell18,025$0.43032.5view
Higgs, DennisDirector 2016-02-04Sell18,025$0.43032.5view
Taylor, Larry DouglasDirector 2016-02-04Buy36,000$0.112430view
Paquette, Raymon Lucien10% Security Holder, Director, Senior Officer 2016-02-04Buy5,000$0.1111290.91view
Hinchcliffe, Robert10% Security Holder, Director, Senior Officer 2016-02-04Buy30,000$0.112430view
Schellenberg, Gary David AlberDirector, Senior Officer 2016-02-04Buy20,000$0.0620783.33view
Schellenberg, Gary David AlberDirector, Senior Officer 2016-02-04Buy13,000$0.0620783.33view

Quarterly/Annual Reports about PID:

    News about PID:

    Articles On GuruFocus.com
    Auxier Asset Management Year-End 2015 Market Commentary Feb 05 2016 
    On Running a Concentrated Portfolio Feb 05 2016 
    Mario Gabelli Comments on Rolls-Royce Holding plc Feb 05 2016 
    Mario Gabelli Comments on Legg Mason Inc. Feb 05 2016 
    Mario Gabelli Comments on JPMorgan Chase & Co. Feb 05 2016 
    Mario Gabelli Comments on International Flavors & Fragrances Feb 05 2016 
    Mario Gabelli Comments on Home Depot Inc. Feb 05 2016 
    Mario Gabelli Comments on Genuine Parts Co. Feb 05 2016 
    Mario Gabelli Comments on CVS Health Corp Feb 05 2016 
    Mario Gabelli Comments on Corning Inc. Feb 05 2016 

    More From Other Websites
    Novartis’s 2015 Revenues Rise 5% at Constant Currencies Feb 01 2016
    How Much Sales Growth Can We Expect from Sanofi’s 4Q15 Earnings? Jan 29 2016
    Will GSK’s Consumer Healthcare Sustain Growth during 4Q15? Jan 29 2016
    GSK’s 4Q15 Earnings: What to Expect from the Vaccines Business Jan 26 2016
    GSK’s 4Q15 Earnings: Will Pharmaceuticals Grow? Jan 26 2016
    Unilever’s Turnover Rose in Fiscal 2015 Jan 20 2016
    Analysts Project Dip in Teva Pharmaceutical Revenues in 4Q15 Jan 15 2016
    JPMorgan Chase Upgraded Unilever’s Rating to ‘Overweight’ Jan 13 2016
    GlaxoSmithKline’s 4Q15 Revenues Expected to Rise Jan 13 2016
    Joint Ventures in US Shale Plays Are Helping Chinese Companies Bring Down Well Drilling Costs Dec 31 2015
    Problems in Increasing CBM Output Leads China to Concentrate on Shale Gas Resources Dec 31 2015
    Teva’s Respiratory Drugs Contribute 11% to Specialty Medicines Dec 14 2015
    The Top 3 Retirement Income ETFs for 2016 Dec 14 2015
    Teva’s Phase III Clinical Trial: Reslizumab Helps Lung Function Dec 02 2015
    FDA Will Review Teva’s BLA for Asthma Drug Reslizumab Dec 02 2015
    How Does the Teva-Heptares Alliance Benefit Teva? Dec 01 2015
    What’s the Teva-Heptares Alliance About? Dec 01 2015
    Teva-Heptares Entered into an Agreement for a Migraine Drug Dec 01 2015
    The Biggest Risks Facing an Anheuser-Busch InBev–SABMiller Deal Oct 13 2015
    The Potential Anheuser-Busch InBev–SABMiller Deal: Shareholder Considerations Oct 09 2015
    This New Hedged Global ETF Meets the Demand of Time Oct 09 2015
    Analyzing Anheuser-Busch InBev’s Revised Bid for SABMiller Oct 08 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK